Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) FCF Margin (2020 - 2022)

Historic FCF Margin for SELLAS Life Sciences (SLS) over the last 4 years, with Q1 2022 value amounting to 715.0%.

  • SELLAS Life Sciences' FCF Margin fell 5348400.0% to 715.0% in Q1 2022 from the same period last year, while for Dec 2022 it was 2380.9%, marking a year-over-year decrease of 20385200.0%. This contributed to the annual value of 2380.9% for FY2022, which is 20385200.0% down from last year.
  • Per SELLAS Life Sciences' latest filing, its FCF Margin stood at 715.0% for Q1 2022, which was down 5348400.0% from 257.79% recorded in Q2 2021.
  • In the past 5 years, SELLAS Life Sciences' FCF Margin ranged from a high of 180.21% in Q4 2020 and a low of 715.0% during Q1 2022
  • For the 3-year period, SELLAS Life Sciences' FCF Margin averaged around 243.18%, with its median value being 218.97% (2021).
  • The largest annual percentage gain for SELLAS Life Sciences' FCF Margin in the last 5 years was -5348400bps (2022), contrasted with its biggest fall of -5348400bps (2022).
  • Over the past 3 years, SELLAS Life Sciences' FCF Margin (Quarter) stood at 180.21% in 2020, then plummeted by -243bps to 257.79% in 2021, then tumbled by -177bps to 715.0% in 2022.
  • Its last three reported values are 715.0% in Q1 2022, 257.79% for Q2 2021, and 180.16% during Q1 2021.